CIK 0001703057 · Large accelerated filer
AbCellera Biologics Inc.
Sign in to watch- Ticker
- ABCL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (604) 559-9005
- Business address
- 150 W 4TH AVENUE, VANCOUVER, British Columbia, Canada, V5Y 1G6
- Open-market buys, last 90 days
- $1,379,662
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$1,379,662. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-24 | Hansen Carl L. G. Chief Executive Officer | Option exercise | +56,125 | $2.70 | $152K | 617,375 |
| 2023-08-24 | Hansen Carl L. G. Chief Executive Officer | Option exercise · Share option (right to buy) | −56,125 | 6,445,316 | ||
| 2023-08-08 | Hayden Michael R Director | Purchase | +30,000 | $5.90 | $177K | 1,303,397 |
| 2023-05-26 | Hansen Carl L. G. Chief Executive Officer | Option exercise | +56,125 | $2.70 | $152K | 561,250 |
| 2023-05-26 | Hansen Carl L. G. Chief Executive Officer | Option exercise · Share option (right to buy) | −56,125 | 6,501,441 | ||
| 2023-05-26 | Booth Andrew Chief Financial Officer | Purchase | +14,500 | $6.85 | $99K | 153,000 |
| 2023-05-26 | Thermopylae Holdings Ltd. 10% owner | Purchase | +153,000 | $6.52 | $998K | 56,012,493 |
| 2023-05-05 | Lecault Veronique Chief Operating Officer | Option exercise | +250,000 | $0.19 | $48K | 2,020,122 |
| 2023-05-05 | Lecault Veronique Chief Operating Officer | Option exercise · Share option (right to buy) | −250,000 | 3,142,689 | ||
| 2023-02-22 | Hansen Carl L. G. Chief Executive Officer | Option exercise | +56,125 | $2.70 | $152K | 505,125 |
| 2023-02-22 | Hansen Carl L. G. Chief Executive Officer | Option exercise · Share option (right to buy) | −56,125 | 6,557,566 | ||
| 2022-12-20 | Booth Andrew Chief Financial Officer | Option exercise | +50,000 | $0.19 | $10K | 188,500 |
| 2022-12-20 | Booth Andrew Chief Financial Officer | Gift | −50,000 | 138,500 | ||
| 2022-12-20 | Booth Andrew Chief Financial Officer | Option exercise · Share option (right to buy) | −50,000 | 5,820,481 | ||
| 2022-12-16 | Thermopylae Holdings Ltd. 10% owner | Purchase | +85,102 | $10.10 | $859K | 55,859,493 |
| 2022-12-01 | Lo Andrew Director | Grant or award · Share Option (right to buy) | +47,231 | 138,556 | ||
| 2022-12-01 | Hayden Michael R Director | Grant or award · Share Option (right to buy) | +47,231 | 497,045 | ||
| 2022-12-01 | Montalbano John S. Director | Grant or award · Share option (right to buy) | +47,231 | 627,045 | ||
| 2022-12-01 | Lecault Veronique Chief Operating Officer | Grant or award · Share Options (right to buy) | +462,535 | 3,392,689 | ||
| 2022-12-01 | Stimart Tryn Chief Legal Officer | Grant or award · Share Options (right to buy) | +346,901 | 2,658,381 |
Page 4 of 11 · 203 trades